Dolly A. Vance
2016
In 2016, Dolly A. Vance earned a total compensation of $1.1M as Executive Vice President, Corporate Affairs, General Counsel and Corporate Secretary at Rigel Pharmaceuticals, a 1% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $159,190 |
|---|---|
| Option Awards | $493,380 |
| Salary | $489,814 |
| Other | $1,794 |
| Total | $1,144,178 |
Vance received $493.4K in option awards, accounting for 43% of the total pay in 2016.
Vance also received $159.2K in non-equity incentive plan, $489.8K in salary and $1.8K in other compensation.
Rankings
In 2016, Dolly A. Vance's compensation ranked 7,580th out of 14,075 executives tracked by ExecPay. In other words, Vance earned more than 46.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,580 out of 14,075 | 46th |
Division Manufacturing | 2,873 out of 5,486 | 48th |
Major group Chemicals And Allied Products | 949 out of 1,900 | 50th |
Industry group Drugs | 735 out of 1,543 | 52nd |
Industry Pharmaceutical Preparations | 586 out of 1,173 | 50th |
Source: SEC filing on March 29, 2017.
Vance's colleagues
We found four more compensation records of executives who worked with Dolly A. Vance at Rigel Pharmaceuticals in 2016.